Classic Benjamin Graham Stock Screener
Free Value Investing for Intelligent Investors across Global Equity Markets, as recommended by Warren Buffett.
| Company Name | MIC | HQ | Fiscal Year | Last Updated | Curr Code | Previous Close | Graham Number | Graham Number(%) | NCAV/ NetNet | NCAV/ NetNet(%) | Graham Grade | Intrinsic Value | Intrinsic Value(%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 81 | REM Group (Holdings) Ltd (1750.HK) | XHKG | HK | 2023-12-31 | 4 days ago | HKD | 0.03 | 0.00 | 0.00% | 0.08 | 251.65% | Ungraded | 0.00 | 0.00% |
| 82 | Inhibikase Therapeutics Inc (IKT) | XNAS | US | 2023-12-31 | 3 days ago | USD | 1.87 | 0.00 | 0.00% | 1.73 | 92.27% | Ungraded | 0.00 | 0.00% |
| 83 | Metrovacesa SA (MS6N.DU) | XDUS | ES | 2023-12-31 | 4 days ago | EUR | 8.07 | 0.00 | 0.00% | 6.18 | 76.64% | Ungraded | 0.00 | 0.00% |
| 84 | TWZ Corporation PCL (TWZ.BK) | XBKK | TH | 2023-12-31 | 2 weeks ago | THB | 0.04 | 0.00 | 0.00% | 0.14 | 352.71% | Ungraded | 0.00 | 0.00% |
| 85 | ARCA Biopharma Inc (ABIO) | XNAS | US | 2023-12-31 | 3 days ago | USD | 3.63 | 0.00 | 0.00% | 2.53 | 69.82% | Ungraded | 0.00 | 0.00% |
| 86 | AN2 Therapeutics Inc (ANTX) | XNAS | US | 2023-12-31 | 3 days ago | USD | 2.40 | 0.00 | 0.00% | 3.24 | 135.16% | Ungraded | 0.00 | 0.00% |
| 87 | CTK Co Ltd (260930.KQ) | XKOS | KR | 2023-12-31 | 4 days ago | KRW | 4,480.00 | 0.00 | 0.00% | 3,016.42 | 67.33% | NCAV (Net-Net) | 3,016.42 | 67.33% |
| 88 | Bonava AB (publ) (BONAV B.ST) | XSTO | SE | 2023-12-31 | 4 days ago | SEK | 10.56 | 0.00 | 0.00% | 27.84 | 263.65% | Ungraded | 0.00 | 0.00% |
| 89 | BioInvent International AB (BINV.ST) | XSTO | SE | 2023-12-31 | 4 days ago | SEK | 23.70 | 0.00 | 0.00% | 15.85 | 66.87% | Ungraded | 0.00 | 0.00% |
| 90 | China Innovation Investment Ltd (1217.HK) | XHKG | HK | 2023-12-31 | 2 weeks ago | HKD | 0.01 | 0.00 | 0.00% | 0.03 | 261.59% | Ungraded | 0.00 | 0.00% |